期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

2型糖尿病患者的代谢指标与血清CA72-4水平的相关性分析

下载PDF
导出
摘要 糖尿病与恶性肿瘤的发生率随着社会的发展日益增高,人们也越来越重视2型糖尿病与恶性肿瘤之间的相互关系,有研究证实2型糖尿病患者发生各种恶性肿瘤的风险性高于正常人群。也有研究表明2型糖尿病患者发生肿瘤的最常见部位为消化道,持续的高血糖状态对于糖尿病患者正常器官形成一种慢性刺激,
作者 王岩 杜振元
机构地区 朝阳市第二医院内分泌科 朝阳市第二医院检验科
出处 《中国实验诊断学》 2016年第5期819-821,共3页 Chinese Journal of Laboratory Diagnosis
关键词 2型糖尿病 CA72-4 相关性分析 患者 代谢指标 恶性肿瘤 血清 高血糖状态
分类号 R587.1 [医药卫生—内分泌]
  • 相关文献

参考文献10

  • 1Kim SH, Baek CO, Lee KA, et al. Clinical implication of elevated CA 19 9 level and the relationship with glucose control state in patients with type 2 diabetes[J]. Endocrine, 2014,46 (2) : 249.
  • 2Buysschaert M, Sadikot S. Diabetes and cancer: A 2013 synopsis [J]. Diabetes Metab Syndr,2013,7(4) :247.
  • 3侯沃霖,张丹丹,陆蔚,殷峻,李鸣,卢逢娣,刘芳,贾伟平.二甲双胍对2型糖尿病患者CA125水平的影响及其相关因素[J].中华医学杂志,2014,94(18):1380-1383. 被引量：20
  • 4Sandhu MS, Dunger DB, Giovannucci EL. Insulin, insulin--like growth factor-I(IGF. I), IGF binding proteins, their biologic in- teractions, and eolorectal Cancer[J]. J Natl Cancer Inst, 2002,94 (13) :972.
  • 5孟馨,贾楠,金智一,刘婷婷.2型糖尿病患者血清CA-125水平与代谢控制指标的相关性研究[J].中国医科大学学报,2014,43(11):996-998. 被引量：8
  • 6李宜,王保法.2型糖尿病患者癌抗原125水平及相关影响因素[J].现代实用医学,2011,23(10):1116-1117. 被引量：3
  • 7Federico A,Morgillo F,Tuccillo C,et al. Chronic inflammatin and oxidativestress in human carcinogenesis[J]. Int J Cancer, 2007,21 (11) :2381.
  • 8Rasouli N,Kem PA. Adipocytokines and the metabolic complica- tions of obesity[J]. J Clin Endoerinol Memb, 2008,93 ( 1 lsuppll) : 64.
  • 9Zhang YH, Yin Y, Zhang HZ, et al. Modifiable risk factors for coloncancer[J]. Chinese Journal of Clinical Ontology, 2003, 30 (7) :501.
  • 10Zhang H,Yu DM,Chen Y,et al. A comparative study on the ex- pression, purification and functional characterization of human adiponectin in pichia pastoris and Escherichia eoli[J]. Labeled Immunoassays Clin Med,2002,9(2) :90.

二级参考文献14

  • 1Oya Uygur-Bayramicli,Resat Dabak,Ekrem Orbay,Can Dolapclo■lu,Mehmet Sargin,Gamze Kilico■lu,Yüksel Güleryüzlü,Alpaslan Mayada■li.Type 2 diabetes mellitus and CA 19-9 levels[J].World Journal of Gastroenterology,2007,13(40):5357-5359. 被引量：64
  • 2Smith U, Gale EA. Cancer and diabetes: are we ready for prime time? [J]. Diabetologia, 2010, 53: 1541-1544.
  • 3Peairs KS, Barone BB, Snyder CF, et al. Diabetes mellitus and breast cancer outcomes: a systematic review and meta -analysis [J]. J Clin Oncol, 2011 , 29 :4046.
  • 4Yang YX, Hennessy S, Lewis JD. Type 2 diabetes mellitus and the risk of colorectal cancer [J]. Clin Gastroenterol Hepatol, 2005, 3: 587-594.
  • 5Evans JM, Donnelly LA, Emslie-Smith AM, et al. Metformin and reduced risk of cancer in diabetic patients [J]. BMJ, 2005, 330: 1304-1305.
  • 6Yang W, Lu J, Weng J, et al. Prevalence of diabetes among men and women in China[J]. N Engl J Med, 2010, 362:1090-1101.
  • 7Pollak M. Insulin and insulin-like growth factor signalling in neoplasia [J]. Nat Rev Cancer, 2008, 8: 915-928.
  • 8Romero IL, McCormick A, McEwen KA, et al. Relationship of type II diabetes and metformin use to ovarian cancer progression, survival, and chemosensitivity [J]. Obstet Gynecol, 2012, 119: 61-67.
  • 9Theriault C, Pinard M, Comamala M, et al. MUC16 (CAI25) regulates epithelial ovarian cancer cell growth, tumorigenesis and metastasis [J]. Gynecol Oncol, 2011, 121 : 434443.
  • 10BoivinM, Lane D, Piche A,et al. CA125 (MUC16) tumor antigen selectively modulates the sensitivity of ovarian cancer cells to genotoxic drug-induced apoptosis [J]. Gynecol Oncol, 2009, 115: 407-413.

共引文献28

中国实验诊断学
2016年 第5期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部